🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

QS CNMD was delighted to receive our Muscular Dystrophy UK Centre of Excellence (with Research) Award on Friday for providing outstanding care, promoting best practice, and demonstrating commitment to improving health and care for people living with muscle wasting and weakening conditions

We have an exciting opportunity to gain some specialist neuro skills and knowledge for physiotherapists with less than one year neuro experience. Please see below advert for more details!

Delighted in Oxford with colleagues focussed on NMD patient research/best care -cant believe 16 yrs since I formed BMS with colleagues- great to see continued success- thanks to sponsors- therapy landscape changed dramatically! UCLH British Myology Society UCL Queen Square Institute of Neurology UCL Brain Sciences

Delighted working with our great team & Dr Vino Vivekanandam delivering this trial impacting clinical practice -UCL researchers deliver breakthrough trial ⁦UCLH⁩ ⁦UCL Brain Sciences⁩ ⁦Muscular Dystrophy UK⁩ ⁦UCL News⁩ ⁦UCL_QS_CNMD⁩ ucl.ac.uk/ion/news/2024/…

ucl.ac.uk/ion/news/2024/…

Lamotrigine as a viable treatment for rare muscle disorder. techexplorist.com/new-hope-patie…

Saw my first pt with poorly understood episodic muscle condition 25y ago! Channeloathies field has exploded since! Now very proud just edited first ever handbook neurologic channelopathies-thanks to fantastic expert colleagues world wide! UCLH UCL Brain Sciences UCL Queen Square Institute of Neurology UCL News

Thanks to the World Muscle Society team for inviting me to present our trial results - lamotrigine and mexiletine are comparable in non-dystrophic myotonia. #WMS2024 UCL Queen Square Institute of Neurology Muscular Dystrophy UK NIHR UCLH Biomedical Research Centre

📢 We are looking for a dynamic, energetic and passionate postdoc fellow to work on in vivo electrophysiology to understand and treat neurological diseases! Deadline 8th January #neuropixels #braindynamics #epilepsy #neurodiseases UCL Queen Square Institute of Neurology DCEE_Lab_UCL tinyurl.com/5n6sad38

Our cochrane review on drug treatments in myotonia is out now! Symptomatic treatments in myotonia are important to consider and can substantially improve quality of life. Prof Michael Hanna UCL_QS_CNMD UCL Queen Square Institute of Neurology UCLH cochranelibrary.com/cdsr/doi/10.10…